777 jilievo
Vikings' passing attack is as potent as ever with Addison's surge as Bears prepare for a rematchWhich Decentralized E-Commerce Platform Should You Choose: Web3Bay (3BAY) or Cortux (CRX)?
Thomas scores 27 as Morgan State downs Campbell 86-76Hospice, or end-of-life care, is an interesting beast. We live in a society that is especially bad at talking about death. Which is kind of funny, since we are all going to experience death, at some point. Today, I want to tell you about a frequent conversation I have with patients when they come into our care. I call it, “You are more than parts,” meaning the material and organs that make up your physical body. So much of healthcare is about curing (or fixing) material problems, not hospice. Hospice is a specialized form of palliative (comfort-based) care. When people are referred to the hospice level of care it is after hearing something like, “There is nothing else we (medicine) can do.” For perfectly understandable reasons, folks (and their families) often come in pretty defeated or depressed. Who wouldn’t be after hearing that? That’s where Hospice of the Panhandle and I, as a Clinical Chaplain and part of the interdisciplinary team providing your care, come in. Hospice is about supporting people through their end-of-life circumstances. Chaplains serve as sojourners or companions on your journey. Our role is not about changing your mind, convincing you of anything, or dragging you from your beliefs into ours. What Chaplains do is assess one’s beliefs and resources, identify concerns/issues, and develop plans of care to address those concerns. Chaplains listen to your stories, especially the things weighing on your spirit. Then, gently observe where there are misalignments of beliefs or breaks in one’s relationships with self, others, the world around them, or the divine. My conversations frequently start with the obvious observation, “You aren’t dead, yet!” Hearing that one has reached the extent of what can be done medically can be devastating. To me, words like cancer or hospice are like lightning strikes – out on the horizon they get your attention, but when striking us or someone we love, that flash is blinding and the boom disorienting. However, you are more than parts that can be replaced through surgery or tweaked by diet or medicines. You are a complete human being, with hopes, dreams, fears, goals, and a whole host of competing needs...and you aren’t dead yet! You, or your loved one, may very well be beyond the limits of curative interventions for the body, but you are so much more than parts. Even when your body is failing, your mind, soul, and spirit can still benefit from attending to those needs. Being at “end of life” frequently gives people permission to focus on finishing well, whatever that means to them. Hospice, as a level of healthcare, is about quality of life, for the remainder of life...this is a very individual process. Let me close with a movie quote – Miracle Max says in The Princess Bride, “There’s a big difference between mostly dead and all dead. Mostly dead is slightly alive.” The goal of your entire hospice team – Doctors, Nurses, Social Workers, Aides, or Chaplains – is to help you live fully, until you are all dead and, therefore, truly beyond the concerns of this life. Blessings to you and your family.
The hematology market is experiencing significant growth driven by the increasing prevalence of blood-related disorders, advancements in research and product development, and the rising number of elderly individuals vulnerable to these conditions. Additionally, the growing adoption and awareness of minimally invasive procedures have further boosted the demand for hematology devices, supporting the market's expansion during the forecast period from 2024 to 2030. LAS VEGAS , Dec. 12, 2024 /PRNewswire/ -- DelveInsight's Hematology Market Insights report provides the current and forecast market analysis, individual leading hematology companies' market shares, challenges, hematology market drivers, barriers, trends, and key market hematology companies in the market. Key Takeaways from the Hematology Market Report As per DelveInsight estimates, North America is anticipated to dominate the global hematology market during the forecast period. In the type segment of the hematology market, coagulation analyzers are estimated to hold a higher share of the hematology market during the forecast period (2024-2030). Notable hematology companies such as Sysmex Corporation, Danaher, Nihon Kohden Corporation, Siemens Healthcare GmbH, Abbott, Boule Diagnostics, Bio-Rad Laboratories, Inc., Biosystems S.A., Diatron, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Erba Mannheim , Ortho Clinical Diagnostics, Abaxis, Heska Corporation, F. Hoffmann-La Roche Ltd, Horiba Ltd., Neomedica, Thermo Fisher Scientific, Agilent, and several others, are currently operating in the hematology market. In December 2024 , Immune-Onc Therapeutics, Inc. shared updated results from its Phase 1b expansion cohort study of IO-202. This first-in-class anti-LILRB4 antibody was evaluated in combination with azacitidine (AZA) for the treatment of chronic myelomonocytic leukemia (CMML). The latest findings were presented during an oral session at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego, California . In December 2024 , BeiGene, Ltd. showcased new clinical data at the 66th American Society of Hematology (ASH) Annual Meeting, highlighting its leadership in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) through the ongoing clinical success of BRUKINSA (zanubrutinib) and notable progress in its pipeline developments. In December 2024 , Nurix Therapeutics, Inc. shared new encouraging clinical data from patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were treated in the Phase 1a/ 1b clinical trial of its Bruton's tyrosine kinase (BTK) degrader, NX-5948. In December 2024 , Bristol Myers Squibb shared results from 18 presentations that underscore its leadership in cell therapy. The data highlighted the effectiveness, durability, and safety of existing therapies for blood cancers, while also showcasing the promise of its pipeline for future applications, including autoimmune diseases. These findings, which span a wide range of potential targets across various disease areas, were presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, California . In December 2024 , Taiho Oncology, Inc. shared the findings of two studies on oral treatments for patients with myelodysplastic syndromes (MDS) and MDS/myeloproliferative neoplasm (MPN) at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH), held from December 7-10, 2024 , in San Diego . To read more about the latest highlights related to the hematology market, get a snapshot of the key highlights entailed in the Global Hematology Market Report Hematology Overview Hematology is a specialized branch of medicine that focuses on the study, diagnosis, treatment, and prevention of blood-related disorders and diseases. It encompasses a wide range of conditions, including anemia, clotting disorders, leukemia, lymphoma, and myeloma. Hematologists work to understand the intricate components of blood, such as red blood cells, white blood cells, platelets, hemoglobin, and plasma, as well as the organs responsible for blood production, like the bone marrow, lymph nodes, and spleen. The field is integral to understanding the body's immune system, oxygen transport, and coagulation processes, as these functions are closely tied to overall health. Advances in hematology, such as molecular diagnostics, targeted therapies, and bone marrow transplantation, have revolutionized the way hematologic diseases are managed. In recent years, hematology has witnessed significant breakthroughs, particularly in understanding the genetic and molecular basis of blood disorders. Cutting-edge therapies, including immunotherapy and gene editing technologies like CRISPR, are providing hope for patients with previously untreatable conditions. For instance, the development of antibody-drug conjugates and CAR-T cell therapies has improved outcomes for individuals with certain blood cancers. In addition, research into hematopoietic stem cell transplantation continues to expand, offering curative potential for diseases such as sickle cell anemia and severe aplastic anemia. As the field evolves, it not only enhances our understanding of blood and its disorders but also contributes to broader medical advancements in oncology, immunology, and regenerative medicine. Hematology Market Insights North America is anticipated to hold the largest share of the global hematology market. This dominance can be attributed to factors such as the growing prevalence of chronic blood disorders, a rising incidence of these conditions among the aging population, and advancements in product offerings, which collectively support the expansion of the hematology market in the region. The increasing number of blood disease cases underscores the demand for hematology in treatment, driving market growth in North America . Additionally, a strong focus on product innovation and the proactive efforts of device manufacturers to penetrate local markets through strategic partnerships contribute further to regional market development. These collaborations are likely to stimulate product demand. Consequently, a combination of factors—such as a large patient base, favorable reimbursement policies, and the introduction of new products—is expected to propel the growth of the North American hematology market during the forecast period. To know more about why North America is leading the market growth in the hematology market, get a snapshot of the Hematology Market Outlook Hematology Market Dynamics The hematology market has undergone significant evolution in recent years, driven by advancements in biotechnology, growing demand for precision medicine, and the increasing prevalence of hematologic disorders such as leukemia, lymphoma, and multiple myeloma. Hematology encompasses both diagnostics and therapeutics, making it a critical domain within healthcare. The rise in patient awareness and improvements in early detection technologies are boosting the diagnostic segment, while innovative treatments, including monoclonal antibodies, CAR-T therapies, and bispecific antibodies, dominate the therapeutic landscape. Additionally, the integration of genetic profiling into routine care has enabled tailored therapies, further propelling the market. One of the key dynamics shaping the hematology market is the shift towards targeted therapies , particularly for rare blood disorders and cancers. Traditional chemotherapies are being replaced or supplemented by highly specific treatments that minimize side effects and improve efficacy. In diseases like hemophilia, the adoption of gene therapies and recombinant products has been transformative. Similarly, the field of immuno-oncology is gaining traction, with treatments like immune checkpoint inhibitors and antibody-drug conjugates showing promise in hematologic malignancies. On the diagnostic side, the emergence of high-throughput technologies such as next-generation sequencing (NGS) and liquid biopsy has revolutionized disease detection and monitoring. These technologies allow for earlier diagnosis, better prognosis determination, and the ability to track disease progression or recurrence with higher accuracy. The growing demand for point-of-care (POC) diagnostics , especially in resource-limited settings, is further expanding the reach of hematology diagnostics to underserved populations. Despite these advances, the market faces several challenges, including high costs associated with novel therapies and diagnostics, regulatory hurdles, and access disparities , particularly in low- and middle-income countries. The complexity of personalized treatments also necessitates robust healthcare infrastructure, which is not uniformly available across regions. Furthermore, the market is highly competitive , with pharmaceutical and biotech companies vying for leadership in niche indications, leading to intense research and development (R&D) activities. Looking forward, the hematology market is expected to continue its growth trajectory, fueled by the integration of artificial intelligence (AI) and machine learning into research, diagnosis, and treatment development. These technologies have the potential to optimize patient outcomes and streamline healthcare delivery. Collaborations between academia, biotech firms, and pharmaceutical giants are likely to accelerate innovation, while regulatory frameworks are anticipated to evolve to better accommodate cutting-edge therapies. As the field advances, the hematology market remains a cornerstone of modern medicine, addressing unmet needs and improving quality of life for patients globally. Get a sneak peek at the hematology market dynamics @ Hematology Market Dynamics Analysis Report Metrics Details Coverage Global Study Period 2021–2030 Hematology Market CAGR ~8% Hematology Market Size by 2030 USD 3 Billion Key Hematology Companies Sysmex Corporation, Danaher, Nihon Kohden Corporation, Siemens Healthcare GmbH, Abbott, Boule Diagnostics, Bio-Rad Laboratories, Inc., Biosystems S.A., Diatron, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Erba Mannheim, Ortho Clinical Diagnostics, Abaxis, Heska Corporation, F. Hoffmann-La Roche Ltd, Horiba Ltd., Neomedica, Thermo Fisher Scientific, Agilent, among others Hematology Market Assessment Hematology Market Segmentation Hematology Market Segmentation By Type: Instruments (Hematology Analyzers, Hematology Cell Counters, Flow Cytometers, Coagulation Analyzers, Others), Kits and Reagents Hematology Market Segmentation By Application: Cardiovascular Diseases, Auto-Immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others Hematology Market Segmentation By Modality: Clinical Laboratory Devices, Point of Care Devices Hematology Market Segmentation By End User: Hospitals & Clinics, Diagnostic Laboratories, Others Hematology Market Segmentation By Geography : North America , Europe , Asia-Pacific , and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the hematology market are set to emerge as the trendsetter explore @ Hematology Companies Table of Contents 1 Hematology Market Report Introduction 2 Hematology Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 Hematology Market Key Factors Analysis 6 Hematology Market Porter's Five Forces Analysis 7 Hematology Market Layout 8 Hematology Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us Interested in knowing the hematology market by 2030? Click to get a snapshot of the Hematology Market Trends Related Reports Hematological Cancer Therapeutics Market Hematological Cancer Therapeutics Market Insight, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key hematological cancer therapeutics companies, including Pfizer Inc., F. Hoffmann-LA Roche Ltd, Sanofi SA, Bristol-Myers Squibb Company, AbbVie Inc, Novartis AG, GlaxoSmithKline PLC, Amgen Inc., Takeda Pharmaceutical Co. Ltd, Johnson & Johnson, Incyte Corporation, AstraZeneca PLC, Celldex Therapeutics Inc., Kite Pharma (Gilead Sciences), Atara Biotherapeutics, Celgene Corporation, Astellas, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, among others. Coagulation Analyzers Market Coagulation Analyzers Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key coagulation analyzers companies, including Abbott Laboratories Inc., Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fisher Scientific Corporation, F. Hoffmann-La Roche Ltd., HORIBA Medical, Nihon Kohden Corporation, Maccura Biotechnology Co., Ltd., Bio-Group Medical System, Genrui Biotech Inc., A&T Corporation, Stago Group, Beijing Succeeder Technology Inc., Helena Laboratories Corporation, BPC BioSed S.R.L., Meril Life Sciences Pvt. Ltd., SCLAVO Diagnostics International, Erba Group, ACON Laboratories, Inc., Haemonetics Corporation , among others. Flow Cytometry Market Flow Cytometry Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key flow cytometry companies, including Thermo Fisher Scientific Inc., BD, Stratedigm, Inc, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Corporation, Agilent Technologies, Inc., Sony Biotechnology Inc., bioMérieux SA, Enzo Life Sciences, Inc., Union Biometrica, Inc., Cytek Biosciences, Sartorius AG, Beckman Coulter , Inc., Apogee Flow Systems Ltd., Molecular Instruments, Inc., Integrated DNA Technologies, Inc., New England Biolabs (NEB), ACROBiosystems , among others. Coagulation Factor Deficiency Market Coagulation Factor Deficiency Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key coagulation factor deficiency companies, including Novo Nordisk, Spark Therapeutics, Sanofi (Genzyme), Alnylam Pharmaceuticals, Pfizer, Biotest AG, Centessa Pharmaceuticals (Apcintex), Staidson Biopharma Inc., Ultragenyx Pharmaceutical, Bayer , among others. About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Contact Us Shruti Thakur info@delveinsight.com +14699457679 https://www.delveinsight.com/medical-devices Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
Claws out over estimated cost of koala national park
Eyes on the skies
The drug dealers, thieves and gang leaders who are granted clemency by Biden By JOE HUTCHISON FOR DAILYMAIL.COM Published: 22:04, 12 December 2024 | Updated: 23:24, 12 December 2024 e-mail 23 shares 110 View comments President Biden commuted the sentences of nearly 1,500 people on Thursday which included drug traffickers, embezzlers and even a leader of a biker gang. In the largest single-day act of clemency in modern history, pardoned 39 Americans convicted of nonviolent crimes and handed out 1,499 commutations. A commutation reduces a sentence that is being served, but does not erase a conviction nor imply innocence, according to the Department of Justice. One of those 1,499 was Rita Crundwell, the former comptroller of the city of Dixon, Illinois , who was involved in stealing over $50 million in city funds. She had served as Dixon's comptroller for over 20 years and pleaded guilty to embezzling the funds in 2013. The stolen money, which she began to accumulate in 1990, was said to be used to support her lavish lifestyle as well as a horse breeding business she ra n. The city managed to recover some of Crundwell's stolen money, after they sold some of her belongings and used it as a recovery fund. State marshals managed to sell off a chandelier made of old revolvers , Western-style furniture, horses, vehicles, jewelry and her homes. In the largest single-day act of clemency in modern history, pardoned 39 Americans convicted of nonviolent crimes and handed out 1,499 commutations Dixon city comptroller Rita Crundwell, left, leaves the Federal Building in Rockford, Illinois, on Wednesday afternoon, April 18, 2012 A chandelier made of revolvers, spurs and cowhide shades is seen Friday, Dec. 7, 2012, inside one of the homes owned by former Dixon comptroller Rita Crundwell She had numerous properties, which included two Dixon homes, her ranch, a home in Florida and prime farmland. She had been originally sentenced to 19 years and seven months behind bars but was released into home detention due to being at high-risk of Covid. The commutations were announced for those who were placed on home confinement during the COVID-19 pandemic. The Biden administration said that individuals who had been placed on home confinement had successfully 'reintegrated into their families and communities'. Walter Diggles was also granted a commutation on his nine-year federal prison sentence for his financial crimes which involved stealing federal grants. Diggles, alongside his wife Rosie and daughter Anita, were sentenced in 2018 after they stole taxpayer funds that were intended to aid victims of Hurricane Rita, Katrina, Ike and Dolly. The Texas-based family managed to devise a scheme to obtain and make use of federal grants that Congress handed down to help those affected by the storms. Diggles was the head of the Deep East Texas Council of Governments and used his power to approve inflated rates and requests for reimbursement from grant funds. He had his wife and daughter prepare many of the aid requests, before he then approved them. His wife and daughter were both sentenced to four-and-a-half years in prison, according to the Federal Bureau of Prisons search tool they are no longer in custody. Crundwell had numerous properties, which included two Dixon homes, her ranch, a home in Florida and prime farmland. One of her former homes in Dixon is seen here Walter Diggles, seen here, was also granted a commutation on his 9-year federal prison sentence for his financial crimes which involved stealing federal grants Rosie Diggles is seen here on the left, with her daughter Anita also pictured on the right In 2009, Bobby Duwayne Froman of Levelland, Texas, pleaded guilty to having a role as the leader of a large-scale methamphetamine trafficking organization. Froman was probed by authorities for drug trafficking activities that he was involved in with his gang the Aces and Eights Outlaw Motorcycle Gang. His posse, of which he was President, acted as a support club of the Bandidos Outlaw Motorcycle Gang and helped distribute crystal meth across West Texas. Froman, seen here, was the President of the Aces and Eights Outlaw Motorcycle Gang A federal grand jury had returned a 110-count indictment that charged him and 28 other defendants for their part in the illicit business. Authorities at the time said his gang would travel to California and acquire the drug by the pound, before transporting it back to Texas. There they mixed the drug with adulterants before splicing it into smaller quantities for sale, accepting money, guns or sex as payment. He too had his sentence commuted Crystal Busby-Tetzlaff was sentenced in 2018 alongside her partner Raymond after pleading guilty to being in possession of crystal meth with intent to distribute. She was sentenced to ten years, with five years of supervised release after authorities seized a total of two pounds of meth from their home. They also found four ounces of the drug in a bag her partner was carrying, as well as scales, numerous plastic baggies and drug ledgers inside. After another raid on a storage unit, a total of six pounds of pure crystal meth was seized by the authorities. RLS Ar Abdul Aziz from Baton Rouge, Louisiana was also among the list of commutations after he was sentenced in 2012 to 30 years behind bars for his part in a crack cocaine distribution scheme. Crystal Busby-Tetzlaff, seen here, was sentenced in 2018 alongside her partner Raymond after pleading guilty to being in possession of crystal meth with intent to distribute After another raid on a storage unit, a total of six pounds of pure crystal meth was seized by the authorities. A stock image of the drug is seen here At the time of his sentencing he was designated as a 'career offender' due to have two prior convictions for federal drug trafficking. He was also handed a commutation. Edward Abell III was also among the list, having pleaded guilty in 2018 to five counts of wire fraud and three counts of money laundering. Read More Biden scorned for 'trashing' his legacy with the largest act of clemency ever after Squad pressure Abell had been the chief financial officer of two Boston-based companies, one of which he managed to embezzle $3.8 million from. He was found to have made out company checks to Pinehurst Tax Associates, a firm that he owned but did not provide any services to his employer. Abell had set up the company as a way to channel embezzled funds into his personal bank accounts and set up fake employees to avoid detection. In 2016 he was let go from the company for unknown reasons, and was hired at another firm where he again kept up the charade - making off with $140,000. Prosecutors said he used the money to purchase a home in Fryeburg, Maine, buy a Porsche Macan as well as a Ford-350 Super Duty. Another on the commutation list was Dwayne Appling, 37, who is serving 27 years in prison after he was found to head an organization that flooded Waterloo, Illinois, with heroin in 2014. Prosecutors at the time said his organization was 'extensive', and involved thirty other individuals who were also similarly prosecuted. Dwayne Appling, 37, was sentenced to 27 years in prison in 2014 after he was found to head an organization that flooded Waterloo, Illinois, with heroin According to a WCFC Courier story from 2011, he had gone on the run after a round of grand jury indictments concerning his heroin ring. That indictment had stemmed from a raid on 17 homes in the city that turned up quantities of heroin, methadone, oxycodone and guns. In 2017, Shelinder Aggarwal of Huntsville, Alabama, was sentenced to 15 years in prison after he was found to have handed out illegal prescriptions for painkillers. Authorities said Aggarwal was the nation's highest Medicare prescriber of opioids during the height of his practice. Read More BREAKING NEWS Biden pardons son Hunter in bombshell U-turn as he claims he was 'unfairly prosecuted' He was found to have conducted health care fraud totaling $9.5 million in unneeded and unused urine tests. Aggarwal was ordered to forfeit $6.7 million and to give up his former clinic, and was ordered to pay $6.7 million in restitution to Blue Cross Blue Shield of Alabama. Authorities said he ran a 'pill mill', and would see around 80 to 145 patients a day in 2012, the majority would get prescriptions. Court records said initial visits lasted five minutes or less, and any follows up would take two minutes or less. He pleaded guilty to having patients undergo unnecessary urine drug tests that he did not need or use, and would bill insurance companies for them. In a plea agreement he said his primary motivation for doing so was for 'financial gain'. Biden said he would be taking more steps in the weeks ahead and would continue to review clemency petitions. The second largest single-day act of clemency was by Barack Obama, with 330, shortly before leaving office in 2017. The clemency follows a broad pardon for his son Hunter, who was prosecuted for gun and tax crimes. Illinois Share or comment on this article: The drug dealers, thieves and gang leaders who are granted clemency by Biden e-mail 23 shares Add commentPARADIGM CAPITAL MANAGEMENT LIVE WITH INDATA
Holy Cow! History: Britain’s lost knocker-uppersFuture of Automotive Logistics Services (3PL and 4PL) Market: Analysis and Leadership by XPO Logistics, GEFCO, Dachser, Cerasis, Expeditors International of Washington, GEODIS, UPS Supply Chain Solutions, Toll Holdings
Shares of moved higher today after the giant was named a top stock for 2025 by and seemed to benefit from broader market news. As a result, the stock finished the session up 3.54%. Alphabet keeps climbing A number of news items seemed to lift the tech stock higher today as it added to last week's gains after the launch of its quantum computing chip, Willow. Today, investors seemed to react to choice to include Alphabet on the list of its 10 favourite stocks to buy for 2025. Alphabet was the only "Magnificent Seven" stock to make the list, and the tech giant is cheaper than most of those peers, still trading at a of 26 even as the stock reached an all-time high today. In other news that could favour Alphabet, the incoming Trump administration wants to drop a car-crash reporting requirement related to autonomous vehicles, which could benefit Waymo as it attempts to scale up its autonomous vehicle business, and investors also seem to think that Trump's choice to head the Federal Trade Commission, Andrew Ferguson, is likely to be friendlier to big tech than Lina Khan, the current head. Finally, a report this weekend said that CEO Sundar Pichand and co-founder Sergey Brin dined with Trump on Thursday, offering another sign of possibly improved relations with the new administration. What's next for Alphabet Alphabet, which still makes most of its money from search advertising, is closely tied to the broader economy, so the stock is likely to continue doing well if the global economy remains stable and continues to expand next year. Given its valuation, it does seem safer than some of its Magnificent Seven peers, though its advertising business still faces risk as technology evolves.NXT Energy Solutions Inc. Announces Board of Director Changes
Louis-Jacques scores 17, Colgate defeats Vermont 65-60( MENAFN - EIN Presswire) Chest Freezers Global market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 13, 2024 /EINPresswire / -- The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only! What Is The Anticipated Growth Rate and Market Size of the Global Chest Freezers Market? The chest freezers market size has seen a significant expansion in recent years. The market is projected to grow from $16.31 billion in 2023 to $18.36 billion in 2024, demonstrating a compound annual growth rate CAGR of 12.6%. The growth during the historical period can be attributed to the rising demand in developing economies, growth in small and medium enterprises, consumer preference for bulk purchasing, increasing focus on food waste reduction, and the expansion of e-commerce. Preview The Global Chest Freezers Market Report: What Does The Future Hold For The Chest Freezers Market? The chest freezers market size is poised for rapid growth in the upcoming years. The market is projected to reach $29.72 billion by 2028, expanding at a compound annual growth rate CAGR of 12.8%. This growth during the forecast period can be attributed to the increasing demand for frozen food, the rise in disposable income, the development of cold storage infrastructure, growing urbanization, migration to cities and the growth of the retail sector. Pre-order The Chest Freezers Global Market Report: What Are The Key Drivers Of The Chest Freezers Market? The rise in demand for frozen food products is anticipated to fuel the growth of the chest freezer market. Frozen food products, preserved by freezing to retain freshness and nutrients, have a longer shelf life for later consumption. The convenience, extended shelf life, and increasing consumer preference for ready-to-eat meals are fueling the demand for frozen food products, making chest freezers essential for optimal long-term storage which maintains the quality, safety, and extended shelf life of frozen items. Which Market Leaders Are Driving The Growth of the Chest Freezer Market? Major players in the chest freezers market include LG Electronics, Midea America Corp., Whirlpool Corp., Sharp Corporation, Liebherr-International GmbH, Electrolux Group, Westinghouse Electric Corp., The Middleby Corp., Dometic Group AB, and more. These major players have been crucial in driving market growth and will continue to play a significant role in its expansion. What Key Trends Are Impacting The Chest Freezer Market? Major companies in the chest freezer market are centered around developing and launching innovative products, offering flexibility to switch between freezer and refrigerator modes, to maintain their competitive edge. The future of cold storage is about to transform through technological innovation, a focus on sustainability, and an expanding market influenced by the consumer demand for frozen goods. How Is The Global Chest Freezer Market Segmented? 1 By Type: 500 And Above Liters, 300 To 500 Liters, 200 To 300 Liters, 200 And Below Liters 2 By Distribution Channel: Online, Offline 3 By Energy Efficiency: High, Medium, Low 4 By Door Type: Solid Door, Glass Door 5 By Application: Retail, Hospitality, Food And Beverage Processing, Cold Storage And Warehouses, Healthcare, Research and Laboratories, Residential, Other Applications What Does The Regional Analysis Tell Us About The Chest Freezer Market? In 2023, North America was the largest region in the chest freezers market. However, Asia-Pacific is expected to be the fastest-growing region in the forthcoming period. The regions covered in the chest freezers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Browse more similar reports- Congenital Heart Disease (CHD) Global Market Report 2024 Esophageal Catheters Global Market Report 2024 High-Frequency Chest-Wall Oscillation Devices Global Market Report 2024 About The Business Research Company Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game. Contact us at: The Business Research Company: Americas +1 3156230293 Asia +44 2071930708 Europe +44 2071930708 Email us at ... Follow us on: LinkedIn: YouTube: Global Market Model: global-market-model Oliver Guirdham The Business Research Company +44 20 7193 0708 email us here Visit us on social media: Facebook X LinkedIn Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. MENAFN12122024003118003196ID1108988684 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.Stock market today: Wall Street’s rally stalls as Nasdaq pulls back from its record
Martha Barrantes Shares Financial Management Strategies for Business Growth and ProductivityLONDON (AP) — When voters around the globe had their say in 2024, their message was often: “You’re fired.” Some 70 countries that are home to half the world’s population held elections this year, and in many incumbents were punished . From India and the United States to Japan , France and Britain , voters tired of economic disruption and global instability rejected sitting governments — and sometimes turned to disruptive outsiders. The rocky democratic landscape just seemed to get bumpier as a dramatic year careened toward its end, with mass protests in Mozambique and Georgia , an election annulled in Romania and an attempt to impose martial law in South Korea. Cas Mudde, a professor of international affairs at the University of Georgia who studies extremism and democracy, summed up 2024 in Prospect magazine as “a great year for the far right, a terrible year for incumbents and a troublesome year for democracy around the world.” One message sent by voters in 2024: They’re fed up. University of Manchester political scientist Rob Ford has attributed the anti-incumbent mood to “electoral long COVID” -– lingering pandemic-related health, education, social and economic disruptions that have made millions of people unhappier and worse off. High inflation, fueled by Russia’s invasion of Ukraine, and mass displacement from that war and conflicts in the Middle East and Africa have added to the global unease. In South Africa, high unemployment and inequality helped drive a dramatic loss of support for the African National Congress, which had governed for three decades since the end of the apartheid system of white minority rule . The party once led by Nelson Mandela lost its political dominance in May’s election and was forced to go into coalition with opposition parties. Incumbents also were defeated in Senegal, Ghana and Botswana , where voters ousted the party that had been in power for 58 years since independence from Britain. Namibia’s ruling SWAPO party extended its 34 years in power in December -– but only by a whisker. Uruguay’s leftist opposition candidate, Yamandú Orsi , became the country’s new president in a November runoff that delivered another rebuke to incumbents. In India, the world’s largest democracy, Prime Minister Narendra Modi’s Hindu nationalist Bharatiya Janata Party lost its parliamentary majority in a shock election result in June after a decade of dominance. It was forced to govern in coalition as the opposition doubled its strength in Parliament. Japanese politics entered a new era of uncertainty after Prime Minister Shigeru Ishiba’s governing Liberal Democratic Party, which has ruled almost without interruption since 1955, suffered a major loss in October amid voter anger at party financial scandals. It now leads a minority government. The U.K.’s July election saw the right-of-center Conservatives ousted after 14 years in office as the center-left Labour Party swept to power in a landslide. But the results also revealed growing fragmentation: Support for the two big parties that have dominated British politics for a century shrank as voters turned to smaller parties, including the hard-right party Reform U.K. led by Nigel Farage. Britain is not alone in seeing a rise for the right. Elections in June for the parliament of the 27-nation European Union saw conservative populists and the far right rock ruling parties in France and Germany, the EU’s biggest and most powerful members. The anti-immigration National Rally party won the first round of France’s parliamentary election in June, but alliances and tactical voting by the center and left knocked it down to third place in the second round, producing a divided legislature and a fragile government that collapsed in a Dec. 4 no-confidence vote. In Austria, the conservative governing People’s Party was beaten by the far-right, pro-Russia Freedom Party in September, though other parties allied to keep it out of a coalition government. Nepotism and political dynasties continued to exert influence -– and to be challenged. After messy elections in February, Pakistan elected Prime Minister Shehbaz Sharif, younger brother of three-time leader Nawaz Sharif. Indonesia, Southeast Asia’s largest democracy, elected President Prabowo Subianto , son-in-law of the late dictator Suharto . Bangladeshi Prime Minister Sheikh Hasina, the world’s longest-serving female leader, won a fourth successive term in a January election that opposition parties boycotted . Months later, her 15-year rule came to a tumultuous end: After mass student-led protests in which hundreds were killed, Hasina was ousted in August and fled to India. In Sri Lanka, voters also rejected a discredited old guard. Voters elected the Marxist Anura Kumara Dissanayake as president in September, two years after an island-wide public movement by an engaged middle class removed the long-ruling Rajapaksa clan. Covert meddling and online disinformation were growing concerns in 2024. Meta, the parent company of Facebook, Instagram and WhatsApp, said that this year it took down 20 election-related “covert influence operations around the world, including in the Middle East, Asia, Europe and the U.S.” It said Russia was the top source of such meddling, followed by Iran and China. In Romania, far-right candidate Călin Georgescu came from nowhere to win the first round of the presidential election in November, aided in part by a flood of TikTok videos promoting his campaign. Amid allegations of Russian meddling, Romania’s Constitutional Court canceled the presidential election runoff two days before it was due to take place after a trove of declassified intelligence alleged Russia organized a sprawling campaign across social media to promote Georgescu. No date has yet been set for a rerun. Moldova’s pro-Western President Maia Sandu won a November runoff against her Moscow-friendly rival in an election seen as pivotal to the future of one of Europe’s poorest nations. Georgia has seen huge protests since an election in October was won by the pro-Moscow Georgian Dream party, which suspended negotiations on joining the European Union. The opposition and the pro-Western president, Salome Zourabichvili, have accused the governing party of rigging the vote with Russia’s help. Possibly the year’s most seismic result, Donald Trump’s victory in November’s U.S. presidential election, has America’s allies and opponents bracing for what the unpredictable “America-first” leader will do with his second term. And instability already reigns on several continents as the year ends. Venezuela has been in political crisis since a July election marred by serious fraud allegations which both President Nicolás Maduro and the opposition claim to have won. Amid opposition protests and a harsh crackdown, opposition candidate Edmundo González went into exile in Spain. In Mozambique, the Frelimo party that has ruled for half a century was declared the winner of an October election that the opposition called rigged. Weeks of ongoing street protests across the country have left more than 100 dead. South Korea’s conservative President Yoon Suk Yeol — weakened after the liberal opposition retained control in an April election -– astonished the country by declaring martial law in a late-night announcement on Dec. 3. Parliament voted to overturn the decision six hours later, and within days voted to impeach Yoon. The crisis in the deeply divided country is far from over. Democracy’s bumpy ride looks likely to continue in 2025, with embattled incumbents facing challenge in countries including Germany, where Chancellor Olaf Scholz lost a confidence vote on Dec. 16, triggering an early election likely in February. Canada will also vote in 2025, with the governing Liberals widely unpopular and increasingly divided after almost a decade in power. Seema Shah, head of democracy assessment at the Stockholm-based International Institute for Democracy and Electoral Assistance, said global surveys suggest support for the concept of democracy remains strong, but the numbers plummet “when you ask people how satisfied they are with their own democracy.” “People want democracy. They like the theory of it," she said. “But when they see it actually play out, it’s not living up to their expectations.” Sheikh Saaliq in New Delhi, Mari Yamaguchi in Tokyo and Gerald Imray in Cape Town, South Africa, contributed to this story.US charges Iranians over deadly strike on American troops
Thomas scores 27 as Morgan State downs Campbell 86-76MINNEAPOLIS (AP) — Donte DiVincenzo scored 26 points as the Minnesota Timberwolves defeated the San Antonio Spurs 112-110 on Sunday night. Rudy Gobert had 17 points and 15 rebounds for the Timberwolves, won won their third straight. Julius Randle had 16 points, while Jaden McDaniels added 12 points and 10 boards for Minnesota. Anthony Edwards, who earlier in the day was fined $100,000 for continued use of profanity in postgame media comments, was held to 14 points, 11 below his season average. After DiVincenzo made one of two free throws with 12.1 seconds left, the Spurs had one more possession down 112-110. San Antonio found a wide-open Jeremy Sochan for 3, but he came up short. Wembanyama led San Antonio with 34 points and eight rebounds. Harrison Barnes had 24 points, Devin Vassell had 22 and Chris Paul dished out 14 assists. Spurs: Trailing by 13 early in the third quarter, Wembanyama keyed a 16-4 run by showcasing his diverse offensive skills. He scored in the low post, hit a 3, made a pair of free throws and drained two midrange jumpers. Timberwolves: Minnesota survived a brutal shooting night from 3-point range, making just 11 of 44 attempts from beyond the arc. DiVincenzo was 5 for 10, but Edwards and Randle combined to go 1 for 16. With 4:44 to play and the game tied at 101, Randle made a driving layup against Wembanyama that was initially whistled for an offensive foul. Timberwolves coach Chris Finch challenged the call, and the basket was allowed to stand. Minnesota didn't trail the rest of the way. In the first quarter, the Timberwolves made just 1 of 11 3-point attempts but went 9 for 9 inside the arc. The Spurs host the Clippers, and the Timberwolves visit Oklahoma City on Tuesday. AP NBA: https://apnews.com/hub/nbaMike Waltz says federal agencies "pointing at each other" on drone sightings